You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Link Details
- Metabolite
- HMDB0000122 (D-Glucose)
- DrugBank ID
- DB06292
- Drug Name
- Dapagliflozin
- Effect
- Decrease
- Biospecimen
- Blood
- P-value
- Not Available
- Beta Estimator
- Not Available
- Percent Change
- Not Available
- Pearson Correlation Coefficient
- Not Available
- Comments
- Not Available
- Kheirandish M, Mahboobi H, Yazdanparast M, Kamal MA: Challenges related to glycemic control in type 2 Diabetes Mellitus patients. Curr Drug Metab. 2017 Jan 15. [PubMed:28093996 ]
- Ghezzi C, Yu AS, Hirayama BA, Kepe V, Liu J, Scafoglio C, Powell DR, Huang SC, Satyamurthy N, Barrio JR, Wright EM: Dapagliflozin Binds Specifically to Sodium-Glucose Cotransporter 2 in the Proximal Renal Tubule. J Am Soc Nephrol. 2017 Mar;28(3):802-810. doi: 10.1681/ASN.2016050510. Epub 2016 Sep 12. [PubMed:27620988 ]
- Zhang M, Zhang L, Wu B, Song H, An Z, Li S: Dapagliflozin treatment for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Res Rev. 2014 Mar;30(3):204-21. doi: 10.1002/dmrr.2479. [PubMed:24115369 ]